 |
| Brian Beck, PhD |
Microbiologics, St Cloud, Minn, has formed a new molecular products division with the acquisition of the assets of Phthisis Diagnostics, including its patented process for designing and manufacturing molecular standards.
These standards are specifically designed to be used as performance controls for a wide variety of molecular instruments and assays in clinical testing.
The company produces an array of lyophilized microorganism products in convenient, ready-to-use formats for quality control of microbiological testing.
Brian Beck, PhD, vice president, Molecular Products and Services, is joining the senior management team. Beck earned his PhD in bacteriology from the University of Wisconsin-Madison and has spent the past 10 years at ATCC, Manassas, Va, where he managed the Microbiology Collection. “I’m quite excited to extend what Microbiologics has done with their culture business and bring that same practical, user-friendly type of format to the molecular diagnostic business,” Beck says.
Microbiologics will be exhibiting at the upcoming Association for Molecular Pathology (AMP) 2013 Annual Meeting, to be held from November 14 to 16 in Phoenix, at booth #231.
[Source: Microbiologics]
